Biosimilar are similar to existing patented, and approved biologic drugs and have similar efficacy, potency, and safety as compared to the original drugs. The biosimilars may have slight structural differences as compared to its biologics but it is required that the safety and efficacy of the biosimilar is not affected as compared to the originator biologics. Additionally, some biosimilars such as monoclonal antibodies can be indicated for multiple indications.

Biosimilar medication can be used for most diseases including chronic disease, cancerous diseases, cardiovascular, and others. However, the oncology disease segment is the key application for the biosimilars market. Biological drugs are the treatment in areas such as oncology, diabetes or autoimmune diseases, among others. Consequently, biosimilars are a reality in the global health panorama. Rising prevalence of chronic diseases across the globe, especially in developing regions owing to rise in sedentary lifestyle and increasing habit of fast food consumption will result in growing number of people suffering from such diseases. Hence, prevalence rate in developed as well as in certain areas in developing nations will augment the demand and adoption rate of biosimilar drugs, fuelling the business growth.

Global Biosimilars Market is segmented based on the Diease as, Oncology, Chronic Diseases, Autoimmune Diseases, Blood Disorders, Growth Hormone Deficiency, Infectious Diseases and Other Diseases. On the basis of Manufacturing Type as, the global Biosimilars market is segregated as, In-House Manufacturing and Contract Manufacturing. On the basis of Product as, the global Biosimilars market is segregated as, (Recombinant Non-Glycosylated Proteins (Insulin, rHGH, Interferon), Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)).

Global Biosimilars market report covers various regions including North America, Europe, Asia Pacific, and Rest of World. The regional Biosimilars market is further bifurcated for major countries including U.S., Canada, Germany, UK, France, Italy, China, India, Japan, Brazil, South Africa and others.

Research Methodology:

To calculate the market size, the report considers the revenue generated from the sales of Biosimilars market manufacturers. The revenue generated from the sales of Biosimilars manufacturer has been calculated through primary and secondary research.

The market size estimation also considered leading players revenues as part of triangulation the key players considered are Sandoz, Pfizer, Teva Pahrmaceutical, Celltrion, Biocon, Amgen, Samsung Biologics, Mylan, Dr. Reddy’s Laboratories and Stada Arzneimittel AG Availability Services among others operating in the Biosimilars market across the globe identified through secondary research and a corresponding detailed analysis of the top vendors in the market. The market size calculation also includes types of segmentation determined using secondary sources and verified through primary sources.

The Biosimilars Market has been segmented as below:

Biosimilars Market, By Product

• Recombinant Non-Glycosylated Proteins

• Recombinant Human Growth Hormone (RHGH)
• Granulocyte Colony-Stimulating Factor (Filgrastim)
• Insulin
• Interferons

• Interferon-Beta
• Interferon-Alpha

• Recombinant Glycosylated Proteins

• Erythropoietin (EPO)
• Monoclonal Antibodies (MABS)

• Infliximab
• Rituximab
• Adalimumab
• Other Monoclonal Antibodies

• Follitropin

• Recombinant Peptides

• Glucagon
• Calcitonin

Biosimilars Market, By Type of Manufacturing

• In-House Manufacturing
• Contract Manufacturing

Biosimilars Market, By Disease

• Oncology
• Chronic Diseases
• Autoimmune Diseases
• Blood Disorders
• Growth Hormone Deficiency
• Infectious Diseases
• Other Diseases

Biosimilars Market, By Region

• North America
• Europe
• Asia Pacific
• Rest of World

Report scope:

The global Biosimilars market report covers detailed study with the underlying influencing factors for the variations in the industry growth trends. The report scope includes market analysis on regional as well as country level.

Reasons to Buy this Report:

• Gain comprehensive insights on the industry trends
• Identify industry opportunities and key growth segments
• Obtain complete market study on the Biosimilars market

Below are our New Reports :-

Bioprocess Optimization and Digital Bio-manufacturing market

Cell Separation and Characterization in Solid Tumors market

Biologic and Medical Imaging Reagents market

Microbial Products market

Next Generation Sequencing NGS Market